MX2011005092A - Composicion de octenidina. - Google Patents

Composicion de octenidina.

Info

Publication number
MX2011005092A
MX2011005092A MX2011005092A MX2011005092A MX2011005092A MX 2011005092 A MX2011005092 A MX 2011005092A MX 2011005092 A MX2011005092 A MX 2011005092A MX 2011005092 A MX2011005092 A MX 2011005092A MX 2011005092 A MX2011005092 A MX 2011005092A
Authority
MX
Mexico
Prior art keywords
octenidine
polyalcohol
optionally
acetal
groups
Prior art date
Application number
MX2011005092A
Other languages
English (en)
Inventor
Ahmet Melih Aydinoglu
Original Assignee
Artan Holding Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40383579&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2011005092(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Artan Holding Ag filed Critical Artan Holding Ag
Publication of MX2011005092A publication Critical patent/MX2011005092A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La invención se relaciona con octenidina o una sal farmacéutica de la misma, en particular dihidrocloruro de octenidina, que se destina para la administración terapéutica mutua de la octenidina en solución con un polialcohol de la fórmula 1: (H-C-OH)a (HO-C-OH)b (H-C-H)C, donde a, b, c son números enteros, donde a+b es al menos 2, de preferencia al menos 3, c se selecciona de 0, 1 o un número de 2 para a+b, opcionalmente además de uno o más grupos aldehído con la condición de que formen acetales (cíclicos) con uno de los grupos hidroxilo o uno o más grupos ceto, opcionalmente como acetal con uno de los grupos hidroxilo, opcionalmente además de uno o más grupos de ácido carboxílico si el polialcohol es un acetal cíclico o acetal, de preferencia con tamaños de anillo de 5 a 7 átomos o un polímero, poliéter o poliéster del mismo, con la condición de que el polialcohol exista como un polímero, poliéter, o poliéster con al menos dos unidades de fórmula 1 si a+b es 2 ó 3. La invención también se relaciona con los kits que contienen esos ingredientes, y el uso de los mismos para tratar infecciones y heridas.
MX2011005092A 2008-11-14 2009-11-13 Composicion de octenidina. MX2011005092A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08450183A EP2201951A1 (de) 2008-11-14 2008-11-14 Octenidin-Zusammensetzung
PCT/EP2009/065111 WO2010055122A1 (de) 2008-11-14 2009-11-13 Octenidin-zusammensetzung

Publications (1)

Publication Number Publication Date
MX2011005092A true MX2011005092A (es) 2011-09-15

Family

ID=40383579

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011005092A MX2011005092A (es) 2008-11-14 2009-11-13 Composicion de octenidina.

Country Status (30)

Country Link
US (2) US8940324B2 (es)
EP (2) EP2201951A1 (es)
JP (1) JP5756018B2 (es)
KR (1) KR20110086718A (es)
CN (1) CN102209542A (es)
AT (1) ATE538788T1 (es)
AU (1) AU2009315654B2 (es)
BR (1) BRPI0915269A2 (es)
CA (1) CA2742921A1 (es)
CO (1) CO6331426A2 (es)
CU (1) CU20110105A7 (es)
CY (1) CY1112730T1 (es)
DK (1) DK2291185T3 (es)
EA (1) EA028177B1 (es)
ES (1) ES2381815T3 (es)
GE (1) GEP20135788B (es)
HK (1) HK1156838A1 (es)
HR (1) HRP20120277T1 (es)
IL (1) IL212596A (es)
MX (1) MX2011005092A (es)
NZ (1) NZ592775A (es)
PE (1) PE20110934A1 (es)
PL (1) PL2291185T3 (es)
PT (1) PT2291185E (es)
RS (1) RS52299B (es)
SI (1) SI2291185T1 (es)
SM (1) SMT201200028B (es)
UA (1) UA108190C2 (es)
WO (1) WO2010055122A1 (es)
ZA (1) ZA201103126B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009049504A1 (de) * 2009-10-15 2011-04-21 Schülke & Mayr GmbH Wund- und Schleimhautantiseptikum auf der Basis von Bispyridiniumalkanen
DE102010025932A1 (de) 2010-07-02 2012-01-05 Schülke & Mayr GmbH Antiseptikum auf der Basis von Bispyridiniumalkanen
DE102010049113A1 (de) * 2010-10-22 2012-04-26 Schülke & Mayr GmbH Mit einer antimikrobiellen Wirkstoffzubereitung getränktes textiles Flächengebilde mit einem Trägermaterial auf Basis von Polyolefin
DE102012007212A1 (de) 2012-04-11 2013-10-17 Merz Pharma Gmbh & Co. Kgaa Zubereitung zur topischen Anwendung auf Schleimhäuten mit Polyhexanid als Wirkstoff
KR101718306B1 (ko) 2015-07-27 2017-03-27 주식회사 퍼슨 옥테니딘염산염(Octenidine dihydrochloride)의 개선된 합성방법과 옥타니딘염산염을 포함하는 새로운 복합제의 제조방법
EA201890813A1 (ru) * 2015-09-25 2018-09-28 ФЛЕКСИГ ПАТЕНТ КОМПАНИ ЭлЭлСи Новые композиции для защиты растений и их применение
PL233480B1 (pl) * 2017-09-28 2019-10-31 Phytopharm Kleka Spolka Akcyjna Koncentrat na bazie soli bis[4-(RHN)-1-pirydynio]alkanów w formie hydrożelu oraz sposób jego otrzymywania
EP3771339A1 (en) * 2019-07-29 2021-02-03 The Procter & Gamble Company Disinfectant composition
CN113827565A (zh) * 2020-06-16 2021-12-24 深圳长久康联生物科技有限公司 一种抗感染喷剂敷料及其制备方法、应用
CN113082029B (zh) * 2021-03-02 2022-07-15 浙大宁波理工学院 一种伤口清洗消毒剂
CN117159784B (zh) * 2023-03-31 2024-04-19 鹏拓生物科技(杭州)有限公司 用于难愈性创面修复的液体创可贴及其制备方法和应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4420484A (en) 1979-08-13 1983-12-13 Sterling Drug Inc. Basic amino or ammonium antimicrobial agent-polyethylene glycol ester surfactant-betaine and/or amine oxide surfactant compositions and method of use therof
DK505588D0 (da) * 1988-02-26 1988-09-09 Jesper Hamburger Middel og anvendelse af samme
DE3925540C1 (es) 1989-08-02 1990-08-30 Schuelke & Mayr Gmbh, 2000 Norderstedt, De
CA2049728A1 (en) * 1990-08-24 1992-02-25 Kenji Kitamura Washing composition capable of preventing and ameliorating skin irritation
US5177065A (en) * 1990-12-26 1993-01-05 Silvetti Sr Anthony N Monosaccharide containing wound healing preparation
DE19647692C2 (de) * 1996-11-05 2002-06-20 Schuelke & Mayr Gmbh Waschendes Desinfektionsmittel zur hygienischen und chirurgischen Händedesinfektion
DE19647892A1 (de) 1996-11-20 1998-06-04 Forschungszentrum Juelich Gmbh Verfahren zur katalytischen, enantioselektiven Reduktion von Ketonen
AUPO690997A0 (en) * 1997-05-20 1997-06-12 Novapharm Research (Australia) Pty Ltd Alkylpolyglucosides containing disinfectant compositions active against pseudomonas microorganism
DE10109925B4 (de) 2001-03-01 2004-11-25 Antiseptica Chemisch-Pharmazeutische Produkte Gmbh Wund- und Schleimhautantiseptikum
DE10205883A1 (de) * 2002-02-13 2003-08-21 Schuelke & Mayr Gmbh Wässriges Antiseptikum auf Basis von Bispyridiniumalkanen
DE10212321A1 (de) 2002-03-20 2003-10-09 Sanguibio Tech Ag Verwendung eines oder mehrerer von Plasma und Zellwandbestandteilen befreiten natürlichen oder modifizierten Sauerstoffbinder zur externen Behandlung offener, insbesondere chronischer Wunden
US8198326B2 (en) * 2004-09-07 2012-06-12 3M Innovative Properties Company Phenolic antiseptic compositions and methods of use
DE102004052308B4 (de) * 2004-10-12 2013-04-04 Divapharma-Knufinke Arzneimittelwerk Gmbh Octenidinhaltige Lutschtabletten gegen entzündliche Erkrankungen des Mund- und Rachenraums
DE102005002645A1 (de) 2005-01-19 2006-07-20 Schülke & Mayr GmbH Alkoholische Zusammensetzungen für die Desinfektion
DE102005002644A1 (de) 2005-01-19 2006-07-20 Schülke & Mayr GmbH Zusammensetzungen für die hygienische Händedesinfektion und die desinfizierende Händewaschung
DE102005058978A1 (de) 2005-08-26 2007-03-29 Bode Chemie Gmbh & Co. Kg Wund- und Schleimhautdesinfektionsmittel
DE102005063375A1 (de) 2005-09-15 2007-04-19 Schülke & Mayr GmbH Antimikrobielle Zubereitungen mit einem Gehalt an Octenidindihydrochlorid verkapselt in Liposomen
DE102005045145A1 (de) 2005-09-15 2007-03-29 Schülke & Mayr GmbH Verwendung von Octenidindihydrochlorid in halbfesten Zubereitungen
FR2907683A1 (fr) 2006-10-27 2008-05-02 De Potter Philippe Viseux Composition medicale pour cicatrisation des plaies et pansements permettant son application
US9555167B2 (en) 2006-12-11 2017-01-31 3M Innovative Properties Company Biocompatible antimicrobial compositions
US20080175801A1 (en) * 2007-01-18 2008-07-24 The Procter & Gamble Company Stable peroxide containing personal care compositions

Also Published As

Publication number Publication date
PE20110934A1 (es) 2011-12-29
AU2009315654B2 (en) 2016-04-21
CN102209542A (zh) 2011-10-05
UA108190C2 (xx) 2015-04-10
CU20110105A7 (es) 2012-01-31
HK1156838A1 (en) 2012-06-22
CA2742921A1 (en) 2010-05-20
RS52299B (en) 2012-12-31
HRP20120277T1 (hr) 2012-05-31
WO2010055122A1 (de) 2010-05-20
SI2291185T1 (sl) 2012-06-29
EP2291185B1 (de) 2011-12-28
IL212596A (en) 2017-09-28
SMT201200028B (it) 2012-07-10
EP2291185A1 (de) 2011-03-09
AU2009315654A1 (en) 2010-05-20
ATE538788T1 (de) 2012-01-15
IL212596A0 (en) 2011-07-31
BRPI0915269A2 (pt) 2016-02-16
PL2291185T3 (pl) 2012-08-31
CY1112730T1 (el) 2016-02-10
US20150126557A1 (en) 2015-05-07
EP2201951A1 (de) 2010-06-30
NZ592775A (en) 2014-01-31
US20110217360A1 (en) 2011-09-08
JP5756018B2 (ja) 2015-07-29
KR20110086718A (ko) 2011-07-29
ZA201103126B (en) 2012-07-25
DK2291185T3 (da) 2012-04-23
PT2291185E (pt) 2012-04-18
EA201100762A1 (ru) 2011-10-31
US8940324B2 (en) 2015-01-27
GEP20135788B (en) 2013-03-11
ES2381815T3 (es) 2012-05-31
JP2012508725A (ja) 2012-04-12
CO6331426A2 (es) 2011-10-20
EA028177B1 (ru) 2017-10-31

Similar Documents

Publication Publication Date Title
MX2011005092A (es) Composicion de octenidina.
MY188960A (en) Cyclic boronic acid ester derivatives and therapeutic uses thereof
CY1119140T1 (el) Συνθεσεις αντικωδικευσης και μεθοδοι κατασκευης και χρησης τους
AU2015205914B2 (en) 1,6- diazabicyclo [3,2,1] octan- 7- one derivatives and their use in the treatment of bacterial infections
MX340533B (es) Derivados de 1,6- diazabiciclo [3,2,1] octan-7-ona y su uso en el tratamiento de infecciones bacterianas.
EA033311B1 (ru) Производные бензоксаборола в качестве антибактериальных средств
MX348974B (es) Derivados 1,6 - diazabiciclo [3,2,1] octan-7-ona y su uso en el tratamiento de infecciones bacterianas.
UA96964C2 (ru) Соединения полициклической мочевины с антибактериальными свойствами
MX361467B (es) Compuestos de isoindolina para uso en el tratamiento de cancer.
EA201390626A1 (ru) Производные гидроксамовой кислоты и применение указанных производных в лечении бактериальных инфекций
EP3216798A3 (en) Ketolide compounds
BR112019018615A2 (pt) compostos antimicrobianos, composições e usos dos mesmos
BR112019024549A2 (pt) compostos derivados de glicopeptídeo e usos dos mesmos
NZ601559A (en) Platelet-derived growth factor compositions and methods for the treatment of tendinopathies
MX357352B (es) Uso de derivados poliaminoisoprenilo en un tratamiento antibiotico o antiseptico.
WO2011153502A3 (en) Anti-inflammatory and quorum sensing inhibition compounds and methods of making and using them
WO2010086617A3 (en) Phosphoantigens for the treatment of burkholderia infections
BR112012000410B8 (pt) uso de benzidamina ou dos sais de adição de ácido, e, composição farmacêutica
FR2908131B1 (fr) Derives d'aminobenzocycloheptene,leurs procedes de preparation et leur utilisation en therapeutique
UA94177C2 (en) antimicrobial composition
UA92423C2 (ru) Антибактериальная композиция
WO2012106722A3 (en) Treatment of bacterial infections
TH125821B (th) องค์ประกอบและวิธีการสำหรับการบำบัดการติดเชื้อแบคที่เรียโดยใช้เซฟทาโรลีน
TH125821A (th) องค์ประกอบและวิธีการสำหรับการบำบัดการติดเชื้อแบคที่เรียโดยใช้เซฟทาโรลีน

Legal Events

Date Code Title Description
FG Grant or registration